Transforming growth factor-b (TGF-b) signaling is known to affect salivary gland physiology by influencing branching morphogenesis, regulating ECM deposition, and controlling immune homeostasis. To study the role of TGF-b1 in the salivary gland, we created a transgenic mouse (b1 glo ) that conditionally overexpresses active TGF-b1 upon genomic recombination by Cre recombinase. b1 glo mice were bred with an MMTV (mouse mammary tumor virus)-Cre (MC) transgenic line that expresses the Cre recombinase predominantly in the secretory cells of both the mammary and salivary glands. Although most of the double positive (b1 glo /MC) pups die either in utero or just after birth, clear defects in salivary gland morphogenesis such as reduced branching and increased mesenchyme could be seen. Those b1 glo /MC mice that survived into adulthood, however, had hyposalivation due to salivary gland fibrosis and acinar atrophy. Increased TGF-b signaling was observed in the salivary gland with elevated phosphorylation of Smad2 and concomitant increase in ECM deposition. In particular, aberrant TGF-b1 overexpression caused salivary gland hypofunction in this mouse model because of the replacement of normal glandular parenchyma with interstitial fibrous tissue. These results further implicate TGF-b in pathological cases of salivary gland inflammation and fibrosis that occur with chronic infections in the glands or with the autoimmune disease, Sjö gren's syndrome, or with radiation therapy given to head-and-neck cancer patients.
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Transforming growth factor-b (TGF-b) signaling is known to affect salivary gland physiology by influencing branching morphogenesis, regulating ECM deposition, and controlling immune homeostasis. To study the role of TGF-b1 in the salivary gland, we created a transgenic mouse (b1 glo ) that conditionally overexpresses active TGF-b1 upon genomic recombination by Cre recombinase. b1 glo mice were bred with an MMTV (mouse mammary tumor virus)-Cre (MC) transgenic line that expresses the Cre recombinase predominantly in the secretory cells of both the mammary and salivary glands. Although most of the double positive (b1 glo /MC) pups die either in utero or just after birth, clear defects in salivary gland morphogenesis such as reduced branching and increased mesenchyme could be seen. Those b1 glo /MC mice that survived into adulthood, however, had hyposalivation due to salivary gland fibrosis and acinar atrophy. Increased TGF-b signaling was observed in the salivary gland with elevated phosphorylation of Smad2 and concomitant increase in ECM deposition. In particular, aberrant TGF-b1 overexpression caused salivary gland hypofunction in this mouse model because of the replacement of normal glandular parenchyma with interstitial fibrous tissue. These results further implicate TGF-b in pathological cases of salivary gland inflammation and fibrosis that occur with chronic infections in the glands or with the autoimmune disease, Sjö gren's syndrome, or with radiation therapy given to head-and-neck cancer patients.
Laboratory Investigation (2010) 90, 543-555; doi:10.1038/labinvest.2010.5; published online 8 February 2010 KEYWORDS: transforming growth factor-b; fibrosis; salivary glands; saliva Transforming growth factor-b1 (TGF-b1) is a multifunctional cytokine that influences salivary gland development and homeostasis. In particular, TGF-b1 is known to regulate ECM deposition not only by inducing biosynthesis of collagens and fibronectin, 1,2 but also by promoting the expression of protease inhibitors. Furthermore, TGF-b1 is able to encourage epithelial-mesenchymal transition in some cells that can result in more ECM-producing myofibroblasts. 3, 4 Tissue damage to the salivary glands from inflammation or radiation exposure can result in reparative TGF-b-induced ECM production. ECM deposition by TGF-b1 shapes epithelial-mesenchymal interactions throughout salivary gland organogenesis as well. Along with regulating mesenchymal production of ECM, TGF-b1 can also influence salivary gland development by controlling cellular growth and differentiation. Secretion of TGF-b1 inhibits the proliferation of epithelial cells by downregulating c-myc while simultaneously increasing the expression of cyclin-dependent kinase (cdk) inhibitors such as p15, p21, and p27. 5 Lastly, TGF-b1 affects salivary gland physiology by regulating angiogenesis 6 and by suppressing inflammation. 7 TGF-b1 and its other two mammalian isoforms, TGF-b2 and TGF-b3, are all expressed in the salivary gland during development, which suggests an important role for this cytokine in glandular organogenesis. 8 Specifically, expression of TGF-b1 seems to coincide with salivary gland differentiation.
9 TGF-b1 is originally detected in both the epithelium and the mesenchyme during the initial bud stage, but becomes immunolocalized to only the branching epithelia later in development. 8 In a 14.5 day post coitum mouse embryo, TGF-b1 mRNA expression is localized in the epithelial end buds, sites of active branching in the developing salivary gland. 10 During this stage of development, TGF-b1 may act in a paracrine manner on the mesenchyme and an autocrine manner on epithelial cell growth. Even though TGF-b1 mRNA is localized at sites of active branching, exogenous TGF-b1 in salivary gland cultures, which mimics overexpression, inhibits branching morphogenesis. 11 Epithelial growth is disrupted and the ducts appear elongated. After glandular development, TGF-b1 expression, however, is localized to the ductal epithelium in the submandibular gland and is absent in the secretory acini. 12, 13 In addition to its role in organogenesis, TGF-b also impacts salivary gland physiology by regulating ECM production, particularly in response to tissue injury. Aberrant expression of TGF-b1 is often associated with cases of pathological fibrosis. In the salivary gland, fibrosis specifically causes constriction of secretory components, leading to hyposalivation and xerostomia.
14 Salivary gland fibrosis typically occurs after repeated episodes of inflammation such as after chronic infections in the glands or with the autoimmune disease, Sjögren's syndrome. Fibrosis of the glands also occurs because of tissue damage from radiation, particularly during radiotherapy treatment of head-and-neck cancer. 15 Interestingly, radiation exposure has been shown to induce TGF-b1 expression. 16 We developed a transgenic mouse that conditionally produces TGF-b1 (b1 glo ) to understand the role of TGF-b signaling in salivary gland development and homeostasis. The transgene requires Cre-mediated excision of an intervening floxed enhanced green fluorescent protein (EGFP) gene in order for a ubiquitous promoter to transcribe a TGF-b1 cDNA. In the transgene, the TGF-b1 cDNA is mutated to prevent the assembly of the latent associated peptide, in order to allow direct binding of the secreted ligand onto the cellsurface receptors. We bred these b1 glo mice to a mouse mammary tumor virus (MMTV) Cre (offspring are MC) transgenic line 17 that strongly expresses the Cre recombinase in both mammary and salivary glands. Broad expression of Cre in these transgenic mice, however, generated a severe phenotype with most of the double-positive (b1 glo /MC) pups either dying in utero or within 24 h after birth. Nonetheless, the effect of TGF-b1 on the salivary gland could clearly be seen in the b1 glo /MC pups with increased mesenchyme and disrupted branching. For those b1 glo /MC mice that survived into adulthood, the salivary glands were severely fibrotic, with signs of atrophy in both granular convoluted ducts (GCDs) and in the acini, and this was associated with hyposalivation.
MATERIALS AND METHODS

Construction of pCLE-b1
glo Transgenic Plasmid To create a transgenic mouse with recombination-activated TGF-b1 expression, we generated the pCLE-b1 glo vector by subcloning an active hemagglutinin (HA) epitope-tagged TGF-b1 cDNA 18 into pCLE. 19 The vector pCLE contains a 1.7-kb b-actin promoter combined with a CMV-IE enhancer (CAG promoter) for ubiquitous expression of the transgene. Downstream from the promoter is a 1-kb EGFP gene that is flanked by loxP sites. A constitutively active 1.2-kb TGF-b1 cDNA was subcloned into the pCLE vector after EGFP. The cDNA contains the porcine sequence for TGF-b1 from pPK9a, where two cysteines (C223 and C225) were mutated to serines to prevent the latent associated peptide, LAP, from assembling around the mature TGF-b1 dimer. 20 PCR mutagenesis was used to add an HA epitope tag onto the ligand to distinguish exogenous TGF-b1 from the endogenous protein. 18 Cell Culture COS7 cells were transfected with pCLE-b1
glo not only to study the efficiency of recombination-mediated expression of TGF-b1 from transgene, but also to test the signaling capability of the epitope-tagged protein. COS7 cells were transfected with either pCLE-b1 glo alone or together with the Cre expression vector pBS185 21 using Lipofectamine LTX (Invitrogen). After overnight incubation, the medium was replaced with serum-free Opti-MEM supplemented with MITO plus (BD Biosciences). The supernatants were collected after 48 h and cells were lysed with T-PER (Pierce) supplemented with a Complete Mini Protease Inhibitor Cocktail (Roche). The COS7 supernatants were treated with 200 mM PMSF (Sigma) and concentrated using an Amicon Ultra centrifugal filter device (Millipore). The supernatants and cell lysates were run on SDS-PAGE gels to test for expression of the epitope-tagged version of TGF-b1 from the transgene (see below). To study TGF-b signaling, untreated COS7 supernatants from the transfected cells were diluted 1:3 with fresh serum-free medium and plated onto 5 Â 10 5 HepG2 cells in a 6-cm culture dish. The cells were lysed after 30 min and cell lysates were run on a Western blot gel to determine the level of phosphorylation of Smad2 (see below).
Generation and Genotyping of b1
glo Mice After testing the pCLE-b1 glo plasmid in vitro, the transgenic vector was microinjected to generate transgenic mice. The founder lines were genotyped by Southern blot analysis. Tail DNA was digested using NheI, a unique restriction enzyme site within the transgenic vector, and the whole transgene (4.5 kb) was radiolabeled for use as a probe. b1 glo Mice were then primarily identified through both PCR and with GFP visualization using a Macro Imaging System (Light Tools Research). The mice were genotyped using the following pair of primers: CAGG: 5 0 -CTCTAGAGCCTCTGCTAACC-3 0 and EGFP: 5 0 -GGTGCAGATGAACTTCAGGG-3 0 . To detect recombination within the transgene, a reverse primer in the TGF-b1 cDNA was designed (b: 5 0 -CGCTTTCCACCAT TAGCAC-3 0 ). Primers were also generated to detect the HA tag (HA For: 5 0 -CATACGACGTGCCAGACTAC-3 0 and pB1-TGA Rev: 5 0 -TCAGCTGCACTTGCAGGAACG-3 0 ) and to ensure integration of SV40 pA (pB1-TGA For: 5 0 -CGT TCCTGCAAGTGCAGCTGA-3 0 and SV40 pA: 5 0 -GATGA GTTTGGACAAACCACAAC-3 0 ). PCR was performed for 40 cycles consisting of 30 s at 941C, 30 s at 571C, and 1 min at 721C. The b1 glo mice were bred to MMTV-Cre mice that were generated as previously described. 17 All experimental studies and procedures were approved by the Animal Care and Use Committee of the National Institute of Dental and Craniofacial Research, NIH.
Saliva Collection Saliva production was tested in the resulting adult b1 glo /MC progeny by using a subcutaneous injection of 0.5 mg/ml pilocarpine (Sigma) at 0.005 mg per 100 g body weight to stimulate salivation. The secreted saliva from pilocarpineinjected mice was collected using a micro-hematocrit tube over a period of 30 min.
Histopathology and Immunohistochemistry
Initial b1 glo /MC mice were often runted and would typically die perinatally. Newborn mice were killed along with control littermates for pathological study. Sagittal sections were used for histological staining and immunohistochemistry. b1 glo / MC Mice that evaded perinatal lethality were killed between 1 week to10 months of age for analysis. Major organs such as heart, liver, skin, pancreas, kidney, and lung were collected along with glandular tissue (salivary, mammary, lacrimal, and so on) from both wild-type and b1 glo /MC mice. Tissues were fixed in 10% buffered formalin and embedded in paraffin. Controls included both b1 glo and wild-type littermates. For histopathology, 5-mm sections were stained with hematoxylin and eosin (H&E), Masson's trichrome, or mucicarmine. The sections were deparaffinized in xylene, rehydrated with descending grades of ethanol, treated with 3% hydrogen peroxide for 30 min, blocked for 30 min, and incubated with primary antibody (see below) in a 1% BSA solution. Next, the sections were treated with the Rabbit on Rodent HRP-Polymer (Biocare) or with a biotinylated secondary antibody (Vector Laboratories) followed by treatment with the Vectastain ABC reagent (Vector Laboratories). Antibody binding was detected using liquid DAB (Biogenex). Immunostaining was performed using the following primary antibodies: 1:100 anti-aquaporin-5 (AQP5; Calbiochem, no. 1078615), 1:400 anti-connective tissue growth factor (CTGF) (Abcam, no. ab6992), 1:500 anti-Smad2, phospho-specific (Ser465/467; Millipore, no. AB3849), 1:500 anti-smoothmuscle actin (Millipore, no. CBL171), and 1:200 anti-TGF-b1 (Promega, G1221). Immunohistochemistry for extracellular TGF-b1 (anti-CC 1-30) 22 and immunofluorescence for AQP5 23 were performed as described previously.
Western Blot and ELISA Salivary glands were collected from wild-type and b1 glo /MC mice and tissue lysates were prepared using T-PER (Pierce) supplemented with a Protease Inhibitor Cocktail (Roche).
Serum from the mice was analyzed by a TGF-b1 ELISA (R&D Systems, no. MB100B). Tissue lysates, cell culture lysates, and cultured supernatants were run on NuPAGE 4-12%Bis-Tris gels (Invitrogen) using MES buffer. Proteins were transferred onto either an Immobilon-P SQ Transfer Membrane (Millipore) or a 0.45-mm nitrocellulose membrane (Invitrogen) depending on the molecular weight of the protein. The transferred proteins were incubated overnight at 41C with a primary antibody (see below) in Tris-buffered saline containing 5% milk and 0.05% Tween-20. The blots were washed and incubated for 1 h with HRP-conjugated secondary antibodies (Santa Cruz Biotechnology). Signal was detected using the SuperSignal West Pico chemiluminescent substrate (Pierce). For Western blots, the following antibodies were used: 1:1000 anti-actin (Millipore, no. MAB1501), 1:5000 anti-green fluorescent protein (Roche, no. 11814460001), 1:100 anti-glyceraldehyde-3-phosphate dehydrogenase (Abcam, no.ab9485), 1:50 anti-HA (Santa Cruz Biotechnology, no.sc-805), 1:500 anti-Smad2 (Invitrogen, no.51-1300), and 1:500 anti-Smad2, phospho-specific (Ser465/467; Millipore, no. AB3849).
Preparation of RNA and RT-PCR Both RNA and DNA were extracted from wild-type and b1 glo /MC salivary glands using the TRIzol reagent (Invitrogen) according to the manufacturer's protocol. The extracted RNA was treated with TURBO DNase (Applied Biosystems). Using random primers (Invitrogen), about 500 ng were reverse-transcribed into cDNA using Super Script III reverse transcriptase (Invitrogen). To detect genomic DNA recombination or RNA expression of the HA tag, PCR amplification was performed using the primers listed above (section Generation and Genotyping of b1 glo Mice).
RESULTS
Generation of b1
glo Mice To create a mouse model using conditional overexpression of TGF-b1, a transgenic construct, pCLE-b1 glo (Figure 1a) , was engineered by subcloning an active HA epitope-tagged version of the TGF-b1 cDNA 18 into pCLE, 19 an expression vector amenable to targeted gene activation through sitespecific recombination. 24, 25 The transgenic vector pCLE-b1 glo contains a global promoter for ubiquitous expression of the TGF-b1 cDNA, but its transcription is blocked by the placement of an intervening floxed EGFP gene. Using the Cre recombinase, however, the EGFP gene can be excised to juxtapose the promoter and the TGF-b1 cDNA together to thereby activate its expression. To test the transgenic construct for recombination-activated TGF-b1 expression, pCLE-b1 glo was transfected into COS7 cells with or without pBS185, 21 a plasmid containing the gene for Cre recombinase. Whereas cells transfected with pCLE-b1 glo alone had no TGF-b1 expression, cells co-transfected with Cre had high levels of TGF-b1 secreted into the culture medium, as determined with both anti-TGF-b1 and anti-HA tag antibodies (Figure 1b) . HepG2 cells were then incubated with transfected cell supernatants to determine whether the secreted epitope-tagged TGF-b1 protein could activate cell signaling. As seen with phosphorylation of the downstream messenger protein Smad2 (Figure 1c) , the secreted epitope-tagged ligand from the dually transfected cells could directly activate the TGF-b signaling pathway.
After the transgenic construct was tested, pCLE-b1 glo was microinjected to create the b1 glo founder lines. The founder lines were genotyped by Southern blot analysis (Figure 1d ) in which a 4.5-kb band was detected corresponding to the size of the transgene. Integration of the transgene was also confirmed using PCR primers to the floxed EGFP gene, the HAtagged TGF-b1 cDNA, and the flanking 2 Â SV40 pA (data not shown). Three of the b1 glo founder lines were selected for further expansion and all of the lines were bred to maintain a heterozygous state (Figure 1e ). All b1 glo mice were healthy and viable, without any toxicity due to transgene integration. In addition, none of the mice showed evidence of any TGFb1-induced pathology due to read through transcription past the floxed EGFP attenuator. 26 Breeding of b1 glo to MMTV-Cre Mice b1 glo Mice were bred with an MMTV-Cre line 17 that strongly, although not uniquely, expressed the Cre recombinase in the salivary glands. The MMTV-LTR used in the Cre transgenic mice predominantly limits its expression to the striated ductal cells of the salivary gland. 27, 28 When b1 glo mice were crossed with the MMTV-Cre line, most pups died in utero, with only about 10% of the b1 glo /MC-positive pups born Effect of TGF-b signaling on salivary gland physiology BE Hall et al instead of the 25% expected. Of the surviving b1 glo /MC pups, most were runted as compared with their littermates. Initially, for all three transgenic lines tested, these b1 glo /MC typically would die within 24 h. However, in one of the b1 glo lines, pups were born that survived beyond the perinatal period. These pups could eventually live beyond 1 year of age. The embryonic and early postnatal lethality, however, seen with most of the b1 glo /MC pups may be due to the broad expression pattern of the Cre recombinase in the MMTV-Cre transgenic line. 17 Even though the phenotype of the newborn b1 glo /MC mice was more severe than expected, the role of TGF-b1 in salivary gland development could still be studied. In the b1 glo /MC mice, the submandibular gland was particularly dysplastic due to TGF-b1 overexpression (Figure 2a and b) . Whereas the submandibular gland was disrupted in the b1 glo /MC mice, the sublingual gland in one line, at least, was histologically normal (data not shown). This phenotype corresponds to the reported Cre expression pattern in MMTV-Cre mice where little recombination occurs in the sublingual gland. 17 In the salivary gland of the b1 glo /MC mice, activation of the TGF-b signaling pathway was seen with increased downstream phosphorylation of Smad2 (Figure 2c and d) . Branching in the submandibular gland was inhibited and the mesenchyme was increased for all three lines of the b1 glo /MC mice. The increased mesenchyme in the glands, however, lacked the collagen fibril trichrome staining typical of progressive fibrosis (data not shown). Immunostaining was performed for AQP5, a functional marker of acinar cell polarity, to further examine the disrupted morphology of the salivary gland in the b1 glo /MC mice. AQP5, a water channel essential for saliva secretion, 29, 30 is localized on the apical membrane of the acinar cells of the control mice as seen with the early terminal-web patterning in the salivary gland. 31, 32 However, b1 glo /MC mice appeared to have aberrant and mislocalized AQP5 staining, possibly as an indirect consequence of the dyplasitc development induced by TGF-b1 overexpression (Figure 2e and f) .
Although salivary glands in the newborn pups were dysplastic, no other organs in the mice showed significant developmental defects that could be detected histologically. No difference could be detected in the circulating levels of total TGF-b1 between b1 glo /MC and control pups using ELISAs (data not shown). As all of the major organs such as the heart and lungs showed no noticeable defects, we suspect that rapid perinatal lethality may be due to a skin barrier defect. In particular, Cre-mediated recombination is shown to occur in the skin using the MMTV-Cre mice 17, 33 and a compromised skin barrier may have been a consequence of the antiproliferative effect of TGF-b1 on epithelial cells. 34 
Lack of Salivation in Adult b1
glo /MC Mice Although most of the b1 glo /MC pups born alive die just after birth, one of our b1 glo lines was able to produce offsprings that did not succumb to perinatal lethality (n ¼ 12; 7 males and 5 females were studied between 1 week to 1 year of age). A few individual mice were even capable of living beyond 1 year of age. However, the percentage of pups dying in utero did not change even while more newborn pups survived into adulthood. Adult b1 glo /MC mice were generally smaller than their littermates with ruffled fur and malformed ears (Figure  3a and b) . This phenotype was likely due to Cre expression in the skin and hair follicles by the MMTV-LTR.
DNA and RNA were extracted from the salivary glands to test for both recombination of the transgene and expression of active TGF-b1 in the b1 glo /MC mice. A 600-bp PCR product was amplified in only the b1 glo /MMTV-Cre mice using primers in the promoter and the TGF-b1 cDNA. The size of the PCR product suggests that the 1-kb EGFP gene was excised in the salivary gland by proper Cre-mediated recombination (Figure 3c ). RT-PCR was then used with a primer specific to the HA to confirm the expression of the transgenic epitope-tagged TGF-b1 in the b1 glo /MC mice. A 400-bp PCR product was generated from the salivary glands with primers from the start of the HA tag to the end of the TGF-b1 cDNA (Figure 3c ).
In the b1 glo /MC mice, Cre-mediated TGF-b1 expression resulted in profound hyposalivation. Although the cholinergic agonist pilocarpine could stimulate a median of 183 ± 64 mg of saliva (5.0 ± 1.8 mg saliva/gram of mouse) from the control mice, no measurable amount of salivation could be induced in the b1 glo /MC mice at 5-10 months of age (Figure 3d) . Most animals showed a dry mouth even with administration of pilocarpine. To determine the cause for this diminished salivation, the salivary glands of b1 glo /MC mice at 1 week to 10 months of age were examined histologically for signs of salivary gland pathology (Figure 3e-h) . At all ages, induction of TGF-b1 triggered aberrant ECM deposition in the salivary glands of the b1 glo /MC mice, which led to progressive fibrosis. The growth of the salivary glands appeared to be severely inhibited in the b1 glo /MC mice between 1 and 4 weeks of age. Even at 1 week of age, initial signs of fibrotic collagen deposition were evident in the submandibular gland along with dilated ducts (Figure 3e and f) . In older mice (between 5and 10 months of age), TGF-b1 overexpression clearly resulted in marked fibrosis and atrophy of the salivary epithelial cells in the submandibular gland (Figure 3g and h) . Inflammatory infiltrates could also be seen in the salivary glands in addition to cellular atrophy. The parotid gland also showed dramatic atrophy in the serous acini with only the ducts still present (data not shown). The sublingual gland, however, was completely unaffected as seen previously in the pups for this line (data not shown). There were no significant pathological lesions seen in most of the other tissues examined. Similar to the observation of Pierce et al, 35 the mammary gland in one adult female b1 glo /MC mouse (7 months of age) showed no increase in periductal connective tissue, even though active TGF-b1 expression was induced using MMTV-Cre. Two male mice, however, had mild tubular atrophy of the testes and one of these had severe acinar atrophy in the pancreas. No difference could be detected between the b1 glo /MC mice and the controls regarding the circulating serum levels of total TGF-b1 (median 67 ± 34 versus 67 ± 19 ng/ml) as well.
Activated TGF-b Signaling in b1
glo /MC Mice Cre-mediated TGF-b1 expression was further examined in the salivary glands of the b1 glo /MC mice. Activation of the TGF-b signaling pathway by Smad2 phosphorylation was only detectable in the salivary glands of the b1 glo /MC mice (Figure 4a ). Two bands were seen using anti-phospho-Smad2 (Ser465/467), an antibody that may also cross-react with phosphorylated Smad3 at its equivalent sites (Ser423/425). Immunostaining of the sections showed elevated TGF-b1expression in the b1 glo /MC salivary glands as compared with that in the controls (Figure 4b and c) . TGF-b1 staining was mainly detected in the ductal cells and was not seen in the few remaining acinar cells. Increased TGF-b1 expression was additionally confirmed using an antibody specific to extracellular TGF-b1 22 ( Figure 4d and e). As with Western blotting, increased Smad2 phosphorylation was also seen in the b1 glo /MC salivary gland using immunohistochemistry (Figure 4f and g ).
Fibrosis and Acinar Cell Atrophy in b1
glo /MC Mice The salivary glands from adult b1 glo /MC mice were then examined to characterize the extent of fibrosis caused by TGF-b1 overexpression. Masson's trichrome staining showed Effect of TGF-b signaling on salivary gland physiology BE Hall et al abnormal collagen deposition throughout the b1 glo /MC submandibular gland (Figure 5a and b) . The blue collagen staining suggests that these glands have increased TGF-b1-induced ECM production. 1 The levels of smooth-muscle actin (Figure 5c and d) and CTGF (Figure 5e and f) were also elevated in the b1 glo /MC salivary glands. In cases of fibrosis, TGF-b1 often increases the expression of these proteins, 1 with smooth-muscle actin being a common marker for activated myofibroblasts in fibrotic lesions. Smooth-muscle actin staining appears periductally either through recruitment of myofibroblasts by TGF-b1 or with the induction of an epithelial-mesenchymal transition through TGF-b signaling. 36 Due to the hyposalivation and fibrosis in the b1 glo /MC mice, the salivary glands were examined for histological changes in acinar cells indicative of functional abnormalities that could result from TGF-b1 overexpression. In the salivary glands of adult b1 glo /MC mice, immunostaining for the essential water channel AQP5 (Figure 6a and b) was decreased. Reduced levels of AQP5 led to decreased saliva secretion and salivary gland hypofunction. 27, 28 Interestingly, downregulation of AQP5 can be caused by radiation-induced injury to the salivary gland 37, 38 and radiation damage can led to increased TGF-b1 expression. 16 Although AQP5 also plays an important role in pulmonary secretions, the b1 glo /MC mice did not show altered expression or trafficking of AQP5 in the lungs (data not shown), suggesting that the MMTV-Cre transgenic line is limiting recombination-mediated TGF-b1 expression primarily to the salivary gland. Along with alterations in AQP5 expression, compromised salivary function also was suggested by using mucicarmine, where decreased red staining indicates reduced mucin production in the b1 glo /MC mice (Figure 6c and d) .
DISCUSSION
By generating b1 glo mice and breeding them to an MMTVCre transgenic line, we set out to study the role of the overexpression of TGF-b1 in the development of the salivary glands. TGF-b1 regulates mucosal immunity and deletion of TGF-b signaling in the salivary gland appears to cause an autoimmune disorder that resembles Sjögren's syndrome. 12, 39 Previously, we conditionally deleted TbRI signaling in mice using MMTV-Cre. 40 Whereas male mice were relatively unaffected by the conditional deletion of TbRI, female mice gradually developed inflammation in the salivary glands. Lack of TbRI, however, did not appear to adversely disrupt salivary gland development in the conditional knockout mice. In contrast, excess TGF-b signaling seen herein clearly inhibits the normal growth of the salivary gland in the b1 glo / MC mice. Over-production of active TGF-b1 ligand resulted in dysplastic growth of the submandibular glands and also disrupted branching in the glands. This likely led to the apparent increase in mesenchyme seen in the b1 glo /MC mice. This phenotype is consistent with those reported in studies in which exogenous addition of TGF-b1 was able to inhibit branching morphogenesis in the salivary glands, 11 lungs, 41 and mammary glands. 35, 42 In terms of salivary gland development, overexpression of active TGF-b1 in the b1 glo /MC mice disrupted normal organogenesis by causing decreased cell proliferation and increased mesenchyme in the developing gland. Proper ECM deposition and degradation is necessary for normal salivary gland growth 43 and ECM remodeling is linked to cell proliferation within the gland. 44 Both of these processes, cell proliferation and ECM deposition, are regulated by TGF-b signaling. Interestingly, some of the developmental growth defects in the b1 glo /MC mice are comparable to those seen during salivary gland development in NOD (non-obese diabetic) mice, a mouse model for Sjögren's syndrome. 44 Furthermore, the changes in glandular homeostasis that occur in NOD mice appear to mimic the reported alterations in ECM turnover that are seen in patients with Sjögren's syndrome. As a principal regulator of ECM production, TGF-b activity may potentially have a role in these observed ECM alterations. In addition to the developmental defects, impaired AQP5 trafficking seen in the b1 glo /MC mice is likewise present in Sjögren's syndrome patients 45 as well as in the NOD mouse model. 46, 47 AQP5 is normally located in the luminal membranes of the acinar cells of the submandibular gland and is essential for saliva secretion, but expression of AQP5 was mislocalized and reduced in the b1 glo /MC mice. In this mouse model, at least, the effects of excess TGF-b signaling in the developing salivary gland probably leads to inhibited proliferation and dysplastic growth of the acinar cells, thereby indirectly resulting in a reduced and altered expression pattern for AQP5. This, in turn, may possibly contribute to the early salivary gland hypofunction seen in the b1 glo /MC mice. At later time points, much of the normal salivary gland parenchyma is replaced with fibrous tissue.
In the b1 glo /MC mice, overexpression of TGF-b1 caused fibrosis of the salivary glands, which was accompanied by atrophy of the GCDs and the acini. Overexpression of active TGF-b1 resulted in excessive deposition of ECM proteins that appeared to severely affect the ability of the b1 glo /MC mice to secrete saliva. Except for the dilated ducts within the b1 glo /MC salivary gland, most of the normal glandular Effect of TGF-b signaling on salivary gland physiology BE Hall et al parenchyma was replaced with fibrotic tissue and this most likely caused the lack of saliva secretion in the adult mice. However, TGF-b1 could have concurrently affected saliva secretion by functioning as a negative regulator of growth and by inhibiting the activity of the Na þ /K þ ATPase. 48 The principal hallmarks of TGF-b-induced fibrosis were seen in the salivary glands of the b1 glo /MC mice. ECM proteins and other indicators of fibrosis such as CTGF and smooth-muscle actin were upregulated in response to the transgenic expression of TGF-b. While acinar atrophy reduced the overall size of the salivary glands in our b1 glo /MC mice, we were still able to study the effect of excess production of TGF-b1 on pathological glandular fibrosis. In humans, increased fibrosis of the salivary glands is seen in geriatric patients, 14 although it is limited and does not affect salivation significantly among healthy elders. 49 The pathology seen in the b1 glo /MC mice is similar to submandibular gland atrophy, which can be caused by ligation of the salivary gland in animal models or in certain cases of salivary adenitis seen in patients. 50, 51 Obstruction of the salivary gland in these cases often leads to fibrosis, degeneration of acinar cells, and dilation of the ducts. Additionally, many patients with Sjögren's syndrome develop progressive fibrosis in their salivary glands, [52] [53] [54] although analysis of TGF-b production in Sjögren's syndrome has yielded conflicting results. 12, 40, 55, 56 Typically, fibrosis occurs when repeated injury, such as chronic inflammation, triggers sustained production of TGF-b because of unresolved tissue damage. Effect of TGF-b signaling on salivary gland physiology BE Hall et al
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Radiotherapy for head-and-neck cancer can also cause fibrosis of the submandibular gland accompanied by a high density of small-dilated ducts 15 and TGF-b1 can be induced by radiation. 16 Such extensive salivary gland fibrosis results in diminished saliva production, which leads to numerous morbidities in patients, including dysphagia, increased oral infections (eg, Candidiasis, dental caries), as well as generalized oral discomfort. Radiation additionally causes downregulation of AQP5 expression in the salivary glands of rats and mice, with reductions in AQP5 staining similar to those we have noted here using the b1 glo /MC mice. 37, 38 The b1 glo /MC mice, therefore, seem to mimic the process of salivary gland fibrosis seen under pathological conditions such as radiation-induced injury and may be a useful model to investigate early interventions to treat fibrosis.
In conclusion, changes in the expression levels of TGF-b can have a profound effect on the physiology of the salivary gland. Lack of TGF-b signaling in the salivary gland appears to trigger autoimmunity. 12, 39, 40 In contrast, excess TGF-b results in the replacement of the normal salivary gland parenchyma with connective tissue. Therefore, proper balance of TGF-b expression and signaling appears necessary for normal salivary gland homeostasis.
